PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment

Elliot Israel*, Loren C. Denlinger, Leonard B. Bacharier, Lisa M. LaVange, Wendy C. Moore, Michael C. Peters, Steve N. Georas, Rosalind J. Wright, David T. Mauger, Patricia Noel, Praveen Akuthota, Julia Bach, Eugene R. Bleecker, Juan Carlos Cardet, Tara F. Carr, Mario Castro, Angeles Cinelli, Suzy A.A. Comhair, Ronina A. Covar, Laura Crotty AlexanderEmily A. DiMango, Serpil C. Erzurum, John V. Fahy, Merritt L. Fajt, Benjamin M. Gaston, Eric A. Hoffman, Fernando Holguin, Daniel J. Jackson, Sonia Jain, Nizar N. Jarjour, Yuan Ji, Nicholas J. Kenyon, Michael R. Kosorok, Monica Kraft, Jerry A. Krishnan, Rajesh Kumar, Andrew H. Liu, Mark C. Liu, Ngoc P. Ly, M. Alison Marquis, Fernando D. Martinez, James N. Moy, Wanda K. O'Neal, Victor E. Ortega, David B. Peden, Wanda Phipatanakul, Kristie Ross, Lewis J. Smith, Stanley J. Szefler, W. Gerald Teague, Abigail F. Tulchinsky, Pandurangan Vijayanand, Michael E. Wechsler, Sally E. Wenzel, Steven R. White, Amir A. Zeki, Anastasia Ivanova

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment'. Together they form a unique fingerprint.

Medicine & Life Sciences